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Abstract: Bacteriophages, or phages, are viruses that infect bacteria and archaea. Phages have diverse
morphologies and can be coded in DNA or RNA and as single or double strands with a large range
of genome sizes. With the increasing use of metagenomic sequencing approaches to analyze complex
samples, many studies generate massive amounts of “viral dark matter”, or sequences of viral origin
unable to be classified either functionally or taxonomically. Metagenomic analysis of phages is still
in its infancy, and uncovering novel phages continues to be a challenge. Work over the past two
decades has begun to uncover key roles for phages in different environments, including the human
gut. Recent studies in humans have identified expanded phage populations in both healthy infants
and in inflammatory bowel disease patients, suggesting distinct phage activity during development
and in specific disease states. In this review, we examine our current knowledge of phage biology
and discuss recent efforts to improve the analysis and discovery of novel phages. We explore the
roles phages may play in human health and disease and discuss the future of phage research.
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1. Introduction
Bacteriophages were independently discovered more than one hundred years ago by both
Frederick Twort and Félix d’Herelle [1,2]. Since their discovery, phages have played a key role in our
understanding of biological processes and have served as essential tools in many seminal biological
works. However, more than a century later, we have only recently begun to appreciate the diversity
and complexity of phages. Most known phages, and specifically 96% of phages examined by electron
microscopy, belong to a single order, Caudovirales, or tailed phages [3]. Until recently, our knowledge of
phage diversity has been limited to phages isolated by plaque assay, a method of culturing phages [4].
This method is robust but requires both a culturable bacterial host and a phage with a lytic lifecycle.
Modern nucleic acid sequencing technology has allowed for the discovery of novel phage genetic
material, but the majority of these putative phage sequences cannot be classified. Termed “viral dark
matter,” more than 80% of virally derived DNA is still a mystery [5]. Coupled to this is the challenge
of identifying bacterial hosts for phages [6]. While often considered exquisitely specific, studies have
increasingly found promiscuous phages infecting bacteria across orders [7]. These challenges provide
numerous opportunities for novel research approaches, but should also serve as a reminder of the
daunting task ahead of virome researchers.
In the past two decades, there has been an explosion of research and interest in the human
microbiota, particularly in the gut [8]. This research has primarily focused on the bacterial portion
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of the microbiota, but more recent work has begun to examine the human virome, wherein phages
comprise the majority of classified sequences [9]. Studies using human stool samples, discussed in
detail below, have suggested important roles for endogenous phages in microbiota development and
dysbiosis. Additionally, recent studies have shown phages are not merely players in the human gut
but are likely important at other sites of the human body [10].
Since the discovery of phages, there has been considerable interest in their use as therapeutic
agents due to their ability to modify or destroy bacteria. Termed “phage therapy”, the use of phages to
treat drug-resistant bacterial infections has stimulated interest in the use of phages to treat a variety of
human diseases [11,12]. However, given our incomplete understanding of the complexity of phage
biology, questions remain as to whether phage therapy would be a safe treatment modality. Often
overlooked in reviews of phage therapy are the important interactions of phages and bacteria in the
healthy human gut, dynamics which could be altered by the introduction of foreign phages.
In this review, we present the current knowledge of phage biology and genetics, focusing on
those genetic elements unique to phages. We then discuss current tools for detection and identification
of novel phages in mixed samples and highlight some of the drawbacks and limitations of current
methods. Then, we turn our attention to human health, discussing what is currently known about
phages and their role in human development and disease. Finally, we look towards the future of
phages both from a research and therapeutic perspective and discuss roles phages could play in the
future of medicine and what discoveries are on the horizon.
2. Phage Biology
It is estimated that there are nearly 1031 viruses on Earth, the vast majority of which are phages [13].
Here we present a brief overview of phage biology; several reviews and other sources have covered this
topic in greater depth [14,15]. Traditionally, phages have been grouped into either lytic or lysogenic
life cycles (Figure 1). Lytic phages infect their target bacterial host and very quickly begin replication
of viral progeny. When sufficient numbers of progeny are produced, the host cells lyse, generally
killing the host in the process. In contrast, lysogenic phages undergo very little replication in their
host. During infection, lysogenic phages instead incorporate their genome into that of their bacterial
host, or may maintain it as a plasmid [16] where it remains and is passively replicated when the
bacterium replicates. These phages are referred to as “prophages.” However, lysogenic phages are
able to become lytic with exposure to certain environmental stimuli [17]. For example, antibiotics and
host inflammation, two common features of modern human life, can both induce lytic lifecycles in
phage [18,19].
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Figure 1. An illustration of the four most well-studied phage lifecycles. Lytic lifecycles involve active
replication of the phage and eventual lysis of host bacteria. Lysogenic phages integrate into the host
genome or insert as plasmids and do not replicate. Chronic infection produces viral progeny but
does not lyse the cell. Phages in a pseudolysogenic state insert DNA, which remains circularized in
the cytoplasm.
More recently, two additional phage lifecycles have been observed (Figure 1). Pseudolysogenic
phages have been described as being in a state of “stalled development”, and can either be incorporated
into the host genome or remain as free DNA in the cytoplasm [17]. This free DNA is distinct from
the plasmid form of some lysogenic phages [20]. Their genetic material is inserted into the host
cell, but rather than incorporating into the host genome, the genetic material remains free in the
cytosol. These phages can undergo lytic or lysogenic lifestyles depending on environmental conditions.
Pseudolysogenic phages may also be referred to as being in a phage “carrier state” [21,22]. The final
type of lifecycle is referred to as chronic infection, which is similar to a lytic lifecycle as the phage is
actively replicating in the host and producing viral progeny. However, unlike in lytic lifecycles, chronic
phages do not lyse their host, but rather, the viral progeny is exported by a variety of mechanisms [20].
Phages are classified according to the International Committee on Taxonomy of Viruses (ICTV)
largely based on genetic and protein sequence homologies [23]. The most well-classified order of phages,
because these were among the first to be carefully studied, is Caudovirales which is further divided
into five families, the three most well-characterized being Myoviridae, Siphoviridae, and Podoviridae.
There are also two more recently described families: Ackermannviridae and Herelleviridae [24,25].
Separated initially by morphological differences, Caudovirales are all double-stranded DNA (dsDNA)
phages marked by the presence of a tail. Over time other types of phages, including the filamentous
single-stranded DNA (ssDNA) phages Inoviridae and the ssDNA Microviridae families were also
described. ICTV currently defines 19 phage families, but the ones highlighted above represent the
most well-characterized.
The classification of phages is far from straightforward. Though some genes have been defined
as “phage hallmark genes”, these features are not present in all phages [26]. In fact, some of the
“hallmarks”, such as terminases, portal proteins, tail proteins, and major capsid proteins, are derived
almost exclusively from studies of Caudovirales. In general, studies focus on identifiable phages, which
are almost always primarily Caudovirales or Microviridae, with few studies targeting other phages.
However, some recent work has been done on the discovery of RNA phages by performing analyses
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on previously generated metagenomics datasets; these studies have identified a trove of novel RNA
phages [27]. Thus, many additional phages may remain to be discovered.
3. Isolation and Genomic Analysis of Phages
3.1. Isolation of Phages
Traditionally, phages have been isolated using plaque assays, performed by growing a lawn
of bacteria on an agar plate and then introducing a suspension suspected of containing phages [4]
(Figure 2). Often phages in suspension must be enriched beforehand, which can be done by inoculating
a liquid culture of bacteria with the suspected phage and allowing the culture to clarify [28]. The plate is
allowed to incubate and is then examined for plaques (clearings in the bacterial lawn), which represent
locations in which the bacteria have been lysed. Once plaque-isolated, sequencing of a phage genome
is relatively trivial, given our ability to bioinformatically assemble single organisms. The advent of
long-read sequencing using systems such as PacBio or Oxford Nanopore has allowed for highly accurate
de novo assembly of bacterial isolate genomes, which was previously challenging with only short-read
Illumina-based sequencing [29]. Long-read technology has recently been applied to sequencing phage
isolates with great success [30], as well as to environmental samples where long-read approaches
provide improved assemblies with similar abundance information to short-read sequencing [31].
The concerted efforts of classical phage isolation via plaque assay in combination with modern
sequencing technologies will undoubtedly fill many holes on our genomic knowledge of bacteriophage.
However, plaque assays have several caveats making them inefficient for comprehensive phage
discovery efforts. One of the biggest drawbacks to plaque assays is their requirement for a culturable
host, as many species of bacteria are currently challenging to cultivate. Additionally, plaque assays are
only able to capture phages which form plaques, which may require additional treatments, such as
mitomycin C, to induce phage into a lytic state [32]. These caveats help explain why we have only
discovered phages infecting 3 of the 61 known bacterial phyla [33].
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Figure 2. A flowchart describing potential methods for analyzing phages from an environmental
sample containing a complex mixture of microbes and viruses. Methods for enriching phages from
these samples include plaque assays, virus-like particle preparations, and single-cell isolation. Nucleic
acid can then be purified from the enriched samples. The nucleic acid can then be sequenced either by
short-read sequencing or long-read sequencing, though generally, a combination of both can produce
the best genome assemblies [34].
Given the challenges of plaque assays, several alternative methods have been employed for
phage discovery. An increasingly widespread approach is metagenomic sequencing [35]. Prior to
metagenomic sequencing, genetic material is enriched and collected via virus-like particle (VLP)
preparation. VLP preparation is a broad descriptor which generally involves removal of bacteria
and free nucleic acid from a sample, thereby enriching for viral particles, which are then broken
open to isolate DNA or RNA. Most VLP methods focus on extraction of DNA. Today there are a
number of chemical and physical isolation methods for VLP preparations including cesium chloride
gradients, microfiltration, and centrifugation [36]. Recently iron chloride flocculation has also been
used to enrich for phages in complex samples [37]. After phage genetic material has been isolated,
it is typically Illumina sequenced to generate large numbers of short, individual sequences. Sequence
data is then assembled into contigs or complete genomes. A similar approach can be used for RNA
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phages by performing a cDNA synthesis step before sequencing. Metagenomic sequencing is not
without its downsides, and chief among these is the aforementioned challenge of dark matter, as it
can be challenging to assemble genomes and/or assign taxonomy to individual reads in the absence
of reference genomes, though these issues may be addressed by improvements to databases and
search and assembly algorithms. In addition, metagenomic assembly is imperfect and may produce
chimeras, misleading interpretation. Thus, while metagenomic sequencing enables an unprecedented
approach to exploring phage diversity, results should always be interpreted with consideration of
these challenges.
More recently, single amplified genomes (SAGs) and virus-SAGs have been used for phage
discovery [38,39]. SAGs represent a potentially powerful tool for both the discovery of phages and the
ability to derive specific bacterial hosts for phages. To perform this method, fluorescence activated cell
sorting (FACS) is applied to a sample of interest to sort and analyze individual bacteria. This method
has been used to capture full bacterial genomes as well as to uncover phage virions in the cytoplasm or
adhered to the surface of these cells and thereby isolate phage genomes directly [38,40]. Virus-SAGs
are an alternative approach to the method above in which viral particles are sorted directly, thus
eliminating most host information [41]. As with any method of analyzing complex communities,
current SAG techniques are biased toward recovery of more common community members. While still
relatively novel in terms of phage research, these methods may open the door to in-depth studies of
bacteria–phage interactions that were previously not possible. Finally, chromatin conformation capture
(3C) is another recent approach for metagenomic analysis that can be applied to phage discovery. 3C is
a method of examining long-range DNA interactions and a modification to this, meta3C, has been
used to derive phage–bacteria interactions in the human gut [42]. The opportunities to clearly define
relationships between phage and their bacterial hosts, as well as to obtain novel phage genomes, are
thus continuing to develop.
3.2. Computational Identification of Phages
Perhaps even more challenging than isolation of phages is the genomic analysis that follows.
De novo identification of phages is a challenging computational problem. The past two decades have
had several pieces of software published presenting novel approaches to this problem. Phage_Finder
was one of the first programs designed for phage discovery [43]. This was followed by Prophinder,
PhiSpy, PHAST, and PHASTER., which all worked to build upon and improve discovery of prophages
in bacterial sequencing data [44–47]. However, none of these programs were designed to discover
non-integrated phage sequences in large-scale data sets. In the past five years, there has been concerted
effort to create tools for the discovery of non-integrated phage in metagenomic data. Both VirSorter and
VirFinder were designed specifically for the identification of non-integrated phage sequences [5,33].
These programs have been applied to a variety of datasets, including metagenomic data sets, sequences
derived from VLP preparations, and SAG datasets. However, even with these advancements, much of
what contributes to viral dark matter remains a mystery.
An examination of the software alone, however, does not fully capture the difficulty in studying
phage biology. Early studies on phages in the human gut were done using VLP. These methods isolate
both eukaryotic viruses and phages and have revealed the gut virome to contain numerous phages [48].
VLP-based studies have largely focused on DNA phages primarily recovering dsDNA Caudovirales as
well as a large fraction of ssDNA phages. However, some of these early studies made use of multiple
displacement amplification (MDA), which has more recently been shown to bias amplification of
ssDNA phages [49,50]. MDA is valuable for analysis of low biomass samples, but in addition to
preferentially amplifying small ssDNA viruses, this method is also blind to RNA viruses. Together
these studies have generated a staggering amount of viral DNA sequence, but due to poor taxonomic
representation in reference databases (of 5639 entries on NCBI Virus, Caudovirales represents 4668
entries or more than 80% of sequences), discovery and knowledge of phage genomics is subject to
extreme reference bias [51].
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Differentiating phage genomes from bacterial genomes can also be challenging due to the
co-evolution of phages and their hosts. Phages often have similar GC content and codon usage
to their hosts [52]. Given this difficulty, other methods have been derived for the identification of
phages in complex samples. Early work on novel phage discovery focused on the identification of
phage attachment sites, the locations where phages integrate into the bacterial genome [43]. This is a
robust method, but can only identify prophages. A second early approach to identification involved
statistical analysis for the enrichment of phage-like genes [44]. However, these approaches are all
alignment-based, and suffer heavily from reference database bias, often resulting in only identification
of Caudovirales-like phages. More recent methods have begun to rely on k-mer analysis where an
identity for a phage is defined by its k-mer usage [5], [33]. A k-mer is simply a “k” length stretch of
nucleotides, wherein a codon would be a 3-mer. While subtle, these studies revealed unique viral
k-mer signatures allowing for identification of phage sequences in mixed samples. K-mers have also
been used to identify putative host bacteria for some phages [53]. Other genomic features that can be
considered when examining samples for phage sequences are the presence of “hallmark” phage tail
genes, limited strand switching of genes, and enrichment of unidentifiable proteins [33]. However,
even given these features, identification of phages remains a challenging problem. With increasing
appreciation of how important these phage populations can be, the number of research groups focused
on resolving these issues continues to increase, which ultimately may yield creative solutions and
improved databases for phage classification.
4. The Role of Phages in the Human Microbiota
As our knowledge of the bacterial populations that inhabit different niches in the human body has
dramatically expanded over the past several decades, researchers have also begun to consider the role
phages play in different human microbiota (Figure 3). Here, we discuss what is currently understood
about phage in these niches.
Viruses 2019, 11, 587 8 of 16
Figure 3. A diagram highlighting regions in the body in which phages have been indicated to play a role.
These regions include the oral microbiota [54,55], the lung microbiota [56,57], the skin microbiota [58–61],
the gut microbiota [62–67], and the vaginal microbiota [68–73].
4.1. Phages in the Infant Gut
Unsurprisingly, the most well-studied area of the human “phageome” is the gut, with most studies
focusing on fecal samples. Studies in both healthy humans and those with chronic and inflammatory
diseases have uncovered interactions between phages, bacteria, and their human hosts. This complex
interplay begins at birth. Intriguingly, at a timepoint when the human gut is relatively sterile with
regard to bacterial populations, phage populations in early-life fecal samples are massively expanded
in comparison to healthy adults [74]. Longitudinal analysis of infants from time of birth to 24 months
of age shows a conserved trend in loss of phage richness over time, as well as a correlation between
loss of Caudovirales phages and gain of Microviridae species, at the same time that bacteria are increasing
in richness. This strong negative correlation between bacteria and phages in the infant virome is still
not fully understood. Interestingly, while by six months of age, mode of birth could not be derived
purely by using analysis of the bacterial microbiome from collected samples [75], even at one year of
age, the composition of the gut phageome could be used to determine the mode of birth for infants [62].
These data suggest a key role for vertical transmission of viruses in early microbiota development and
in the gradual definition of a mature microbiota composition.
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4.2. Phages in the Adult Gut
A majority of studies of the adult phageome have focused on the association of phages with
human disease, limiting our knowledge of a “healthy” phageome. Studies of bacteria in the human
gut have shown high degrees of inter-personal variation, so much so as to allow fingerprinting of an
individual by their gut microbes [63]. However, variation between phageomes of individuals has been
shown to be even greater than that of bacteria [64]. Even with this extreme variability, the phageome
appears to be highly stable, perhaps more so than the associated bacteria in the gut, even in the presence
of strong modifications to the microbiota, such as fecal microbiota transplant (FMT) [65]. Given their
ability to evolve rapidly, the human gut likely contains dozens of “novel” phage species within a
single individual. However, even with this high degree of mutation and evolution, it appears a “core
virome” exists in the gut, providing temporal stability by interacting with the core bacteria found across
humans [66]. Phages in the oral microbiota, another important component of the overall gut microbiota,
appear to play a role in both homeostasis and disease. The role of phages in the oral microbiota appears
to be complex and diverse with both positive and negative relationships found between bacteria and
phages [54]. Analysis of broad interactions between bacteria and phages in the human oral cavity
revealed a network of cross-infective phages with broad host tropism [55]. These cross-infective phages
were found to be positively correlated with commensal bacteria but negatively correlated with bacteria
known to cause periodontal disease, indicating a potential protective effect by resident phages in the
mouth. This temporal stability of phages in the oral cavity appears to be similar to the stability of
phages in the distal gut, which may suggest a broad role for phages in microbiota regulation.
The association of phage with intestinal disease has been explored in several recent studies.
Inflammatory bowel disease (IBD) is a broad term including several disorders involving chronic
inflammation of the intestinal tract. Two types of IBD are ulcerative colitis (UC) and Crohn’s disease
(CD). Both of these conditions are characterized by long-lasting inflammation and periods of increased
inflammation and symptoms, referred to as flares. Dozens of studies over the past decade have
revealed a broad loss of bacterial diversity in IBD patients [67,76]. Analysis of a longitudinal cohort
of IBD patients revealed that in contrast to a decrease in bacterial diversity, there is an expansion of
phages in IBD patients as compared to their healthy household controls [77]. Specifically, while both
UC and CD patients exhibit increased phage richness, these different IBD subtypes are associated with
distinct phage populations. Analysis of correlation between bacteria and phages showed an inverse
correlation between specific bacterial taxa and Caudovirales phages, a correlation that was stronger
in CD than UC patients. Overall, this study indicated potentially important disease-specific roles
for bacteria–phage, or possibly phage–host interactions in IBD. Studies in mice have recapitulated
these findings. A recent study in mice deficient in adaptive immunity revealed an inverse relationship
between bacteria and phages during T-cell induced colitis [78]. Further, human IBD-derived viral
contigs recruit more phage reads from colitic mice than from healthy mice, indicating that colitic mice
have similar phage alterations as humans with IBD. Together, these studies define a disease-associated
relationship between gut bacteria and phage in both humans and mice.
Equally ill-defined are the interactions of phages and eukaryotic cells in the human gut. Treating
germ-free mice with a mixture of phages or phage DNA stimulates IFN-γ [79]. This response is mediated
through TLR-9, a nucleotide-sensing receptor involved in several immune response pathways, and
leads to exacerbated colitis. Additionally, among IBD patients receiving FMT, patients with strong
therapeutic responses were found to contain less Caudovirales DNA than non-responders. It has also
been shown that phages are continuously transcytosed by gut epithelial cells [80]. This mechanism
may explain the presence of phages across body sites even in the absence of disease. However, studies
are still few in number, and we lack a full understanding of the consequences that systemic acute or
chronic phage exposure may have on human health.
Phages have also been found to play a role in Clostridium difficile (C. diff ) infection. C. diff is a
bacterial pathogen that causes pseudomembranous colitis with infection often following antibiotic
treatment [81]. While it has been understood for decades that commensal bacteria play a role in
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protecting against colonization, it is not clear what role phages may play in C. diff infection and
pathogenesis. Phages have been known to induce and alter virulence in bacteria, and C. diff is no
exception, with several phages being shown to encode virulence factors [82]. Many of the currently
known phages infecting C. diff have been found in the form of prophages, and some sequenced isolates
contain five or more prophages as well as several cryptic plasmids which could be episomal phages [83].
Most of our current knowledge of C. diff phages involves studies in which prophages were induced
into lytic lifecycles. Combining the knowledge of virulence-encoding phages in C. diff and phage
induction by antibiotics, one can speculate that it is not merely bacterial depletion playing a role in
C. diff infection. However, the role of phages in C. diff is still poorly understood, and it is not clear if
resident phages in the gut could contribute to C. diff virulence.
These studies provide broad insight into the potential role phages play in human diseases of the
gut. Further, they illustrate the need for continued research into gut phages as well as consideration of
phages when designing microbiota studies. Finally, it is important to note that many of these studies
were performed on stool samples, which may not fully represent the true diversity of phages in the
human gut and do not provide any spatial information about phage distribution along the length of
gastrointestinal tract or within intestinal substructures, such as crypts and villi [84]. Stool samples also
favor discovery of phages which are either free virions, readily inducible or contained within bacteria
that are shed in the stool, which likely does not fully capture all phage. This is an important point,
especially when considering FMT, wherein donor stool samples are transferred to recipients as part of
treatment for diseases like C. diff and IBD. Phages will also be a part of the donor FMT, and thus will
play a role in FMT engraftment and success.
4.3. Phages on the Skin
It will come as no surprise that as with many other organ systems, the skin has its own unique
repertoire of bacteria and phages. Though a single organ, the skin contains multitudes of spatially
organized microbiota. These regions vary both in moisture and exposure to external environments,
leading to the development of unique microbial communities. As with the bacteria in these sites, the
phages in different skin sites appear to have significant differences in composition [85].
Interpersonal variation in the skin phageome is higher than variation over time, however, and
the skin phageome is less temporally stable than the phageome at other sites. Though some evidence
exists for the variability of the skin virome over time, other studies have found a core phageome in
the skin [58]. It also appears that, unlike eukaryotic viruses which were found across many body
sites, particular phages had specificity for particular body sites. Correlations between phage and
Propionibacterium acnes suggestive of an antagonistic relationship have been observed, and analysis of
healthy patients and those with acne found increased prevalence and abundance of phages targeting
P. acnes in healthy patients [59]. Additionally, it appears there is also a correlation with phage abundance
and age. Further examination of P. acnes phages revealed a strong correlation between specific phages
and bacterial strains, highlighting the specificity and diversity of phage–host interactions in the skin [60].
In general, research into the role of phages in human skin disease has not been extensive. One of
the few studies examining the lesion microenvironment in patients with psoriasis, a chronic skin
inflammatory condition, revealed several phage-derived genes in Staphylococcus strains with increased
virulence-related genes [61]. Phages targeting Staphylococcus have been found to be components of the
core phageome in skin [58]. Further exploration will be critical to define interactions between phage
and inflammatory skin conditions.
4.4. Phages in the Vaginal Microbiota
The vaginal microbiota is unique compared with other body sites, being generally dominated by
a single genus of bacteria Lactobacillus, at least in healthy Western Caucasians [86]. Unsurprisingly,
many Lactobacillus-associated phages have also been identified in the vaginal tract, including several
prophages [68]. Studies of Lactobacillus iners, a strain associated with dysbiosis in the vagina, report
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an increase in CRISPR expression, indicating a potential resistance to phage infection by some
taxa [69]. Even in women with highly distinct vaginal bacterial communities, however, distinct viral
community structures were not observed [70]. In patients with bacterial vaginosis (BV), which is
usually characterized by the presence of other bacterial taxa, including Gardnerella, it has been shown
there is an increase in phage load [71]. Gardnerella itself carries several prophages [72], but no significant
difference in phage induction has been observed between BV patients and healthy controls [73].
In general, however, the role phages play in BV and in the homeostasis of the vaginal microbiota is
not well-understood.
4.5. Phages in the Lungs
As in all the other body sites discussed, research is beginning to uncover the role of phages in
health and disease of the lungs. Studies in healthy human lungs have shown a resident population of
phages in the lower lung, which appears to play a role in the stimulation of immune pathways [56].
A study in samples collected from patients with cystic fibrosis, a genetic disorder characterized by the
production of thick mucus that interferes with breathing and organ function, revealed a filamentous
bacteriophage that increased the virulence of Pseudomonas aeruginosa [57]. It was also shown that
patients whose lungs contained this phage were more likely to have chronic P. aeruginosa infection,
as well as increased resistance to antipseudomonal antibiotics. Analysis of the phage found it allowed
bacteria to sequester these antibiotics, revealing a potential role in antibiotic resistance in P. aeruginosa.
Across all body sites discussed, it is clear phages are more than merely bystanders in the
environment, and they are playing roles in both homeostasis and disease pathogenesis. The presence
of “core phageomes” in many body sites argues for conserved roles of phages in the human microbiota.
It is also apparent that phage interactions are a key component of dysbiosis, either by regulating or
facilitating the invasion of exogenous bacterial taxa.
5. The Future of Phages in Research and Health
The future of phages in research and healthcare is only just beginning to be realized. Outside
of the realm of phage therapy, dozens of avenues for phages have opened. From bioengineering to
cancer research, applications for phages are numerous. Originally thought of merely as antibiological
particles, we now recognize them as bacterial viruses with broad potential. To close, we will briefly
discuss areas of human health that have thus far not been explored in regard to phages.
It is often highlighted in research on endogenous phages and even in general microbiota studies
that little is known about the human virome. The past decade has revealed a key role for the phages
in gut health, but there is limited evidence as to their role at other sites. Many key questions remain
regarding phages in both maintenance of a healthy microbiota and their role in disease and dysbiosis.
Discussed above is the ability for phages to enter the circulatory system and access nearly any region
of the human body. Given this faculty for translocation, we would be remiss to not consider phages
when studying disease at nearly any site.
An obvious potential area of importance for phages is in skin diseases. However, both eczema and
psoriasis have limited studies examining the skin virome and even fewer studies examining the virome
at sites of skin irritation. Psoriasis, which forms plaques, could yield compelling evidence of phage
interactions in disease. Phages have also been neglected in the study of autoimmune diseases. It has
now become apparent that infection with eukaryotic viruses increases the risk of several autoimmune
diseases [87]. Studies have found that humans develop anti-phage antibodies [88], indicating the
potential for phage immunogenicity [89]. However, the effects of phages, both endogenous and those
that enter from the environment, have not been examined in these disorders.
There are many potential therapeutic uses of phages to treat human diseases, and the future of
phages is bright. It is clear by the surge in publications and popular press involving phages that we
are in the midst of a phage renaissance, and much ongoing work may have dramatic implications for
human health and disease. Many areas of human health have been neglected when it comes to phage
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research, but this is being gradually remedied, and we are entering an unprecedented age of discovery
when it comes to phages. Twenty years ago, Roger Hendrix made the statement, “All the world’s a
phage” [90], and today, this has never been more true.
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